|
FY2026
12 months to May 31, 2026
|
FY2025
12 months to May 31, 2025
|
FY2024
12 months to May 31, 2024
|
FY2023
12 months to May 31, 2023
|
FY2022
12 months to May 31, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales (exclusive of intangible amortization) | |||||
| Gross margin | |||||
| Operating expenses | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Amortization of intangibles | |||||
| Change in fair value of contingent consideration | |||||
| Acquisition, restructuring and other items, net | |||||
| Total operating expenses | |||||
| Gain on sale of assets | |||||
| Operating loss | |||||
| Other expenses | |||||
| Interest income (expense), net | |||||
| Other income (expense), net | |||||
| Total other income, net | |||||
| Loss before income tax expense (benefit) | |||||
| Income tax expense (benefit) | |||||
| Net loss | |||||
| Loss per share | |||||
| Basic (usd per share) | |||||
| Diluted (usd per share) | |||||
| Weighted average shares outstanding | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...
